Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang, Hui, Zhang, Yuntao, Huang, Baoying, Deng, Wei, Quan, Yaru, Wang, Wenling, Xu, Wenbo, Zhao, Yuxiu, Li, Na, Zhang, Jin, Liang, Hongyang, Bao, Linlin, Xu, Yanfeng, Ding, Ling, Zhou, Weimin, Gao, Hong, Liu, Jiangning, Niu, Peihua, Zhao, Li, Zhen, Wei, Fu, Hui, Yu, Shouzhi, Zhang, Zhengli, Xu, Guangxue, Li, Changgui, Lou, Zhiyong, Xu, Miao, Qin, Chuan, Wu, Guizhen, Gao, George Fu, Tan, Wenjie, Yang, Xiaoming·2020·Cell
DOI 10.1016/j.cell.2020.06.008

Cited by (749)

Items 401–500 of 749

  1. A Brief Review on Medicinal Plants-At-Arms against COVID-19
    Shivani Srivastava, Fangzhou He, Yuanding Huang, Meng Niu, Alok Adholeya, Weng Kung Peng · 2023 · Interdisciplinary Perspectives on Infectious Diseases
  2. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
    Guidenn Sulbarán, Pauline Maisonnasse, Axelle Amen, Grégory Effantin, Delphine Guilligay, Nathalie Dereuddre‐Bosquet, Judith A. Burger, Meliawati Poniman, Marloes Grobben, Marlyse Buisson et al. · 2022 · Cell Reports Medicine
  3. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection In Vitro
    Ning Luan, Tao Li, Yunfei Wang, Han Cao, Xingxiao Yin, Kangyang Lin, Cunbao Liu · 2022 · Frontiers in Immunology
  4. Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
    Jinkai Zang, Yannan Yin, Shiqi Xu, Weihua Qiao, Qiuyue Liu, Dimitri Lavillette, Chao Zhang, Haikun Wang, Zhong Wei Huang · 2022 · Frontiers in Immunology
  5. Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers
    Hamed Zare, Hadis Rezapour, Alireza Fereidouni, Saboura Nikpour, Sara Mahmoudzadeh, Simon G. Royce, Mohammad Fereidouni · 2022 · Immunity & Ageing
  6. Avoiding culture shock with the SARS-CoV-2 spike protein
    Benjamin G. Hale · 2021 · eLife
  7. Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model
    Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita M. Shete, Priya Abraham, Krishna Mohan Surapaneni, Gajanan N. Sapkal, Chandrashekhar Mote, Dimpal A. Nyayanit, Nivedita Gupta, V K Srini et al. · 2020
  8. The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
    Linghong Huang, ZhengRong Jiang, Jingxiong Zhou · 2022 · Frontiers in Endocrinology
  9. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training
    Veronika Pilchová, Chittappen Kandiyil Prajeeth, Paula Jendrny, Friederike Twele, Sebastian Meller, Isabell Pink, Anahita Fathi, Marylyn M. Addo, Holger Andreas Volk, Albert D. M. E. Osterhaus et al. · 2023 · Journal of Virological Methods
  10. Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants
    Lei He, Qian Wu, Zhaoyong Zhang, Lingling Chen, Kuai Yu, Leibin Li, Qiong Jia, Yanqun Wang, Jianqiang Ni, Chuanbin Wang et al. · 2024 · Molecular Pharmaceutics
  11. Molecular basis of Ad5-nCoV vaccine-induced immunogenicity
    Dongyang Dong, Yutong Song, Shipo Wu, Busen Wang, Cheng Peng, Weiping Zhang, Weizheng Kong, Zheyuan Zhang, Jingwen Song, Lihua Hou et al. · 2025 · Structure
  12. An Appraisal of the Current Scenario in Vaccine Research for COVID-19
    Wai Chin Chong, Dinesh Kumar Chellappan, Shakti Dhar Shukla, Gregory Mark Peterson, Rahul P. Patel, Niraj Kumar Jha, Rajaraman D. Eri, Kamal Dua, Murtaza M. Tambuwala, Madhur D. Shastri · 2021 · Viruses
  13. Development of synthetic antigen vaccines for COVID-19
    Maria da Conceição Viana Invenção, Alanne Rayssa da Silva Melo, Larissa Silva de Macêdo, Thaís Souto Paula da Costa Neves, Cristiane Moutinho Lagos de Melo, Marcelo Nazário Cordeiro, Marcus Vinícius de Aragão Batista, Antônio Carlos de Freitas · 2021 · Human Vaccines & Immunotherapeutics
  14. Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19
    Ming Hao, Dongxu Wang, Qianyun Xia, Shaoning Kan, Lu Chang, Huimin Liu, Zhijing Yang, Weiwei Liu · 2022 · Frontiers in Immunology
  15. Pilot genome-wide association study of antibody response to inactivated SARS-CoV-2 vaccines
    Ping Li, Dawei Shi, Wenlong Shen · 2022 · Frontiers in Immunology
  16. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants
    Bhaswati Chatterjee, Suman Siddharth Thakur · 2021 · Expert Review of Vaccines
  17. The development of China’s vaccine industry in the past decade: the perspective from drug regulatory science
    Guan-Jie Wang, Mingli Shao · 2021 · Human Vaccines & Immunotherapeutics
  18. Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins
    Jing Chen, Xu Wang, Letian Li, Lichao Yi, Yuhang Jiang, Pengfei Hao, Zhiqiang Xu, Wancheng Zou, Peiheng Li, Zihan Gao et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  19. Vacunas contra la COVID-19
    Alberto J Villena · 2021 · Ambiociencias
  20. Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021
    Javier Silva Valencia, Percy Soto-Becerra, Stefan Escobar-Agreda, Manuel Fernández-Navarro, Miguel Moscoso‐Porras, Lely Solari, Percy Mayta‐Tristán · 2023 · Travel Medicine and Infectious Disease
  21. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2
    Miguel Ángel Casillas Santana, Farid Alonso Dipp Velázquez, Carolina Sámano Valencia, Alan Martínez Zumarán, Norma Verónica Zavala-Alonso, Ricardo Martínez Rider, Marco Felipe Salas Orozco · 2021 · Medicina
  22. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome
    Chong Hyun Shin, Ki‐Hye Kim, Subbiah Jeeva, Sang‐Moo Kang · 2021 · Cells
  23. Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases
    Suyi Luo, Lihong Yin, Xiaohui Liu, Xuemei Wang · 2025 · Biosensors
  24. Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3–12 Years Old
    Khaled F. Greish, Abdulla Ismaeel AlAwadhi, Ahmed Jaradat, Amer Jebril Almarabheh, Marwa Ali Almadhi, Jaleela Sayed Jawad, Basma Alsaffar, Ejlal Alalawi, Adel Alsayyad, Afaf Merza et al. · 2022 · Vaccines
  25. Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
    Nawal Al Kaabi, Yunkai Yang, Salah Eldin Hussein, Tian Yang, Jehad Abdalla, Hui Wang, Zhiyong Lou, Agyad Ebrahim Bakkour, Afnan Arafat, Zhiwei Jiang et al. · 2023 · Vaccines
  26. Optimizing the Potential of Artificial Intelligence in Education Management for Era 5.0
    Tarsisius Susilo, Sovian Aritonang · 2023 · al-fikrah Jurnal Manajemen Pendidikan
  27. Evaluation of Stability, Inactivation, and Disinfection Effectiveness of Mpox Virus
    Yuwei Li, Shiyun Lv, Yan Jun Zeng et al. · 2024 · Viruses
  28. Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris
    Tongxin Zhao, Sheng Liu, Pengyan Wang, Yanfang Zhang, Xinrui Kang, X. Pan, Lin-Jie Li, Dedong Li, Ping Gao, Yaling An et al. · 2024 · PLoS Pathogens
  29. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2
    Chuanjun Shu, 南京医科大学公共卫生学院，江苏 南京211166，中国, Xuan Huang, Huihao Tang, Dingding Mo, Jianwei Zhou, Cheng Deng, 南京师范大学生命科学学院，江苏 南京 210023，中国, 南京医科大学生物医学工程与信息学院，江苏 南京 211166，中国, 南京大学医学院附属金陵医院生殖医学中心，江苏 南京 211166，中国 et al. · 2021 · 动物学研究
  30. SARS-CoV-2 Inactivation Simulation Using 14 MeV Neutron Irradiation
    Fang Liu, Zhengtong Zhong, Bin Liu · 2021 · Life
  31. Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Heedo Park, Mee Sook Park, Jong Hyeon Seok, Jaehwan You, Jeonghun Kim, Jeonghun Kim, Man‐Seong Park · 2022 · The Journal of Microbiology
  32. Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2022 · PLoS Pathogens
  33. Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
    Josephine Wambani, Patrick Kirsteen OKOTH · 2022 · The Egyptian Journal of Internal Medicine
  34. Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study
    Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Preeda Vanichsetakul, Saraiorn Thonginnetra, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal et al. · 2022 · Vaccines
  35. A Review on DNA Vaccines in Pre-Clinical Trials Against SARS-CoV-2
    Dinesh Kumar Lakshmi Narayanan, Sinouvassane Djearamane, Shivkanya Fuloria · 2022 · Journal of Experimental Biology and Agricultural Sciences
  36. Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines
    Zi‐Wei Ye, Yilan Fan, Kaiming Tang, Chon Phin Ong, Cuiting Luo, Hon-Lam Chung, Tsun-Lam Leong, Ronghui Liang, Wai‐Yin Lui, Runhong Zhou et al. · 2022 · International Journal of Biological Sciences
  37. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
    Tao‐Hsin Tung, Xiaoqing Lin, Yan Chen, Meixian Zhang, Jiansheng Zhu · 2022 · Human Vaccines & Immunotherapeutics
  38. Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells
    Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, Amitabha Mukhopadhyay, Amit Awasthi, Tripti Shrivastava, Manidipa Banerjee · 2022 · ACS Infectious Diseases
  39. Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications
    Congshan Jiang, Kaichong Jiang, Xiaowei Li, Ning Zhang, Wenhua Zhu, Liesu Meng, Yanmin Zhang, Shemin Lu · 2022 · Journal of Pharmaceutical Analysis
  40. Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
    Nawal Al Kaabi, Yun Kai Yang, Yu Liang, Ke Xu, Xue Feng Zhang, Yun Kang, Yu Qin Jin, Jun Wei Hou, Jing Zhang, Tian Yang et al. · 2023 · Signal Transduction and Targeted Therapy
  41. Advanced Vaccine Design Strategies against SARS-CoV-2 and Emerging Variants
    Jianzhong Zhang, Yutian Xia, Xuan Liu, Gang Liu · 2023 · Bioengineering
  42. Live unattenuated vaccines for controlling viral diseases, including COVID‐19
    Jiming Chen · 2020 · Journal of Medical Virology
  43. A review of COVID-19 vaccines in development: 6 months into the pandemic
    Merlin Sanicas, Melvin Sanicas, Doudou Diop · 2020 · Pan African Medical Journal
  44. Characteristics and Developments in Mesenchymal Stem Cell Therapy for COVID-19: An Update
    Lu Sang, Xiaoqin Guo, Jie Shi, Shike Hou, Haojun Fan, Qi Lv · 2021 · Stem Cells International
  45. Clustering cases of Chlamydia psittaci pneumonia mimicking COVID-19 pneumonia
    Wei Zhong Zhao, Lei He, Xingzhi Xie · 2021 · World Journal of Clinical Cases
  46. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate
    Zibin Tan, Canchai Yang, Po‐Han Lin, Sherif Ramadan, Weizhun Yang, Zahra Rashidi, Shuyao Lang, Fatemeh Shafieichaharberoud, Jia Gao, Xingling Pan et al. · 2024 · Advanced Healthcare Materials
  47. Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
    Rui Qiao, Jiayan Li, Jiami Gong, Yuchen Shao, Jizhen Yu, Yumeng Chen, Yinying Lu, Luxuan Yang, Luanfeng Lin, Zixin Hu et al. · 2025 · Vaccines
  48. Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm)
    Aleksandar Cvetković-Vega, Diego Urrunaga‐Pastor, Percy Soto-Becerra, Luis Edgardo Figueroa-Montes, Lizette Fernández Bolívar, Sergio Enrique Alvizuri-Pastor, Martin Oyanguren-Miranda, Ibeth Melania Neyra Vera, Elizabeth Carrillo-Ramos, Arturo Ampelio III Sagastegui Soto et al. · 2022 · Travel Medicine and Infectious Disease
  49. SARS-CoV-2 S Glycoprotein Stabilization Strategies
    Borys Pedenko, Guidenn Sulbarán, Delphine Guilligay, Grégory Effantin, Winfríed Weissenhorn · 2023 · Viruses
  50. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
    Chimuka Handabile, Marumi Ohno, Toshiki Sekiya et al. · 2024 · Scientific Reports
  51. Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines
    Ziyu Liu, Liyan Cai, Man Xing, Nan Qiao, Jiaojiao Liu, Xuejun Li, Chiyu Zhang, Naijun Tang, Zhelong Xu, Yingying Guo et al. · 2024 · Biosafety and Health
  52. Evaluation of an RBD-nucleocapsid fusion protein as a booster candidate for COVID-19 vaccine
    Bruno Vinícius Santos Valiate, Júlia Teixeira de Castro, Tomas G. Marçal, Luis Adan Flores Andrade, Livia I. Oliveira, GABRIELA BARBI FREIRE MAIA, Lídia Faustino, Natália Satchiko Hojo-Souza, Marconi Augusto Aguiar dos Reis, Flávia Fonseca Bagno et al. · 2024 · iScience
  53. Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development
    Keda Chen, Chaonan Li, Ying Wang · 2021 · Vaccines
  54. Impact of Prior Infection on Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Syrian Hamsters
    Cheng Zhang, Zhendong Guo, Nan Li, Huan Yong Cui, Keyin Meng, Lina Liu, Li Zhao, Shan Zhang, Cheng‐Feng Qin, Juxiang Liu et al. · 2021 · Frontiers in Microbiology
  55. Neutralization Heterogeneity of Circulating SARS-CoV-2 Variants to Sera Elicited by a Vaccinee or Convalescent
    Meng Zhang, Yixin Gong, Shunchang Jiao · 2022 · Future Virology
  56. Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection
    Mary Duro, C Almeida, Inês Duro, Amélia Sarmento · 2022 · Irish Journal of Medical Science (1971 -)
  57. An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)
    Zhujun Jiang, Haishuang Lin, Haoran Zhang, Ningning Shi, Zhetao Zheng, Liangzhen Dong, Yuelin Yang, Qing Xia · 2022 · Vaccines
  58. Neutralizing antibodies and cellular immune response after two doses of inactivated SARS-CoV-2 vaccine in China
    Lina Yan, Zhongxin Zhao, Zhendong Wang, Xiao Xiao, Panpan Liu, Wenkang Zhang, Xiaolan Gu, Bang Li, Liping Yu, Xue‐jie Yu · 2022 · Expert Review of Vaccines
  59. Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
    Agustín Valenzuela-Fernández, Romina Cabrera-Rodríguez, Laura Ciuffreda, Silvia Pérez-Yanes, Judith Estévez‐Herrera, Rafaela González‐Montelongo, Julia Alcoba-Flórez, Rodrigo Trujillo‐González, Diego García-Martínez de Artola, Helena Gil-Campesino et al. · 2022 · Frontiers in Bioengineering and Biotechnology
  60. Coronavirus disease-19 vaccine development utilizing promising technology
    Yihan Wang, Man Xing, Dongming Zhou · 2020 · Current Opinion in HIV and AIDS
  61. Advanced Nanobiomedical Approaches to Combat Coronavirus Disease of 2019
    Halle Lutz, Kristen D. Popowski, Phuong‐Uyen Dinh, Ke Cheng · 2020 · Advanced NanoBiomed Research
  62. CURRENT UPDATES ON COVID-19 VACCINES
    Shashi Kiran Misra, Kamla Pathak, Devender Pathak · 2021 · Asian Journal of Pharmaceutical and Clinical Research
  63. Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2
    Maren Bormann, Lukas van de Sand, Oliver Witzke, Adalbert Krawczyk · 2021 · Klinische Monatsblätter für Augenheilkunde
  64. COVID-19, des vaccins à la vitesse de l’éclair
    Yanis Feraoun, Pauline Maisonnasse, Roger Le Grand, Anne‐Sophie Beignon · 2021 · médecine/sciences
  65. A dossier on COVID-19 chronicle
    Rufaida Rufaida, Tarique Mahmood, Ismail Kedwai, Farogh Ahsan, Arshiya Shamim, Mohammad Shariq, Saba Parveen · 2021 · Journal of Basic and Clinical Physiology and Pharmacology
  66. Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum
    Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, G. Pérez, Victor A. R. Pereira, Carlos Henrique Dumard, Francisca Hildemagna Guedes-da-Silva, Ana C. Vicente Santos, Monique dos Santos Leandro et al. · 2022 · Frontiers in Immunology
  67. Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID‐19 vaccine
    Zhangkai Jason Cheng, Huimin Huang, Qiwen Liu, Ruifen Zhong, Zhiman Liang, Mingshan Xue, Mingtao Liu, Siping Li, Hongman Wang, Peiyan Zheng et al. · 2022 · Journal of Medical Virology
  68. Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate
    Shan Mei, Zhangling Fan, Xiaoman Liu, Fei Zhao, Yu Huang, Liang Wei, Yamei Hu, Yu Xie, Liming Wang, Bin Ai et al. · 2022 · Frontiers in Immunology
  69. Psychiatric symptoms before and after COVID-19 vaccination: A cohort study of hospitalized schizophrenia patients
    Feng Jia, Cuizhu Dong, Hong Guo · 2022 · Asian Journal of Psychiatry
  70. Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans
    Verónica Galván, Jorge Fabián Quarleri · 2021 · GeroScience
  71. Broad-spectrum affinity chromatography of SARS-CoV-2 and Omicron vaccines from ligand screening to purification
    Jing Ma, Xiaoyan Dong, Yan Ping Sun, Qinghong Shi · 2025 · Journal of Chromatography A
  72. A Universal Therapeutic Vaccine Leveraging Autologous Pre‐Existing Immunity to Eliminate in Situ Uniformly Engineered Heterogeneous Tumor Cells
    Fuhua Wu, Zhaofei Guo, Jialiang Yang, Yangsen Ou, Xiejin Xie, Hu Liao, Chenqi Guo, Yuxi Zhan, Haiping Wu, Rui Min Hu et al. · 2025 · Advanced Materials
  73. Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants
    Jing Ma, Yongdong Huang, Guodong Jia, Xiaoyan Dong, Qinghong Shi, Yan Ping Sun · 2024 · International Journal of Biological Macromolecules
  74. Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development
    Chiranjib Chakraborty, Yi-Hao Lo, Manojit Bhattacharya, Arpita Das, Zhi‐Hong Wen · 2025 · Molecular Therapy — Nucleic Acids
  75. Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection
    Hao Sun, Xiaojuan Su, Lingyi Huang, Dezhi Mu, Yi Qu · 2021 · Biomolecules
  76. Exploring Rapid and Effective Screening Methods for Anti-SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Longitudinal Vaccinated Populations
    Caiqin Hu, Dan Li, Zhanmou Liu, Li Ren, Junwei Su, Meiling Zhu, Yi Feng, Zheng Wang, Qiang Liu, Biao Zhu et al. · 2022 · Pathogens
  77. COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
    Atul A. Deodhar, Suleman Bhana, Kevin L. Winthrop, Lianne S. Gensler · 2022 · Rheumatology and Therapy
  78. A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannan
    Yunxia He, Weili Yu, Lijuan Shen, Wenying Yan, Lucheng Xiao, Jinming Qi, Tao Hu · 2022 · International Journal of Biological Macromolecules
  79. Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study
    Rongdong Huang, Xiaoqin Liu, Fangqin Xie · 2022 · Diabetes Therapy
  80. COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
    Liang Hong, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Zhao Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu et al. · 2022 · Cell Discovery
  81. Review on COVID-19 Vaccines
    Liyana Majid, Sengamalam Radhakrishnan, Ramachandran Vignesh, Ravindran Muthukumarasamy · 2022 · Research Journal of Pharmacy and Technology
  82. Failla Memorial Lecture: The Many Facets of Heavy-Ion Science
    Marco Durante · 2021 · Radiation Research
  83. Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
    Jaewoo Hong, Hyunjhung Jhun, Yeo-Ok Choi, Afeisha S. Taitt, Suyoung Bae, Young-Min Lee, Chang‐Seon Song, Su Cheong Yeom, Soohyun Kim · 2021 · Immune Network
  84. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
    Hui Yin Lim, Masita Arip, Abdul Aziz Al-Fattah Bin Yahaya, Seyed Davoud Jazayeri, Sibrandes Poppema, Chit Laa Poh · 2021 · Frontiers in Bioscience-Landmark
  85. Microneedles enable the development of skin-targeted vaccines against coronaviruses and influenza viruses
    Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, Huy Truong Nguyen, Vo Van Giau · 2021 · Pharmaceutical Development and Technology
  86. A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool
    German I. Todorov, Vladimir Nikolaevich Uversky · 2020 · Biomolecules
  87. Sinopharm's BBIBP-CorV Vaccine Effectiveness on Preventing Hospital Admission and Deaths: Results From a Retrospective Study in the Emirate of Abu Dhabi, United Arab Emirates (UAE)
    Farida Ismail Al Hosani, Anderson Eduardo Stanciole, Bashir Aden, Andrey Timoshkin, Omar Najim, Walid Abbas Zaher, Fatima AlSayedsaleh AlDhaheri, Shereena Al Mazrouei, Tahir Aziz Rizvi, Farah Mustafa · 2021 · SSRN Electronic Journal
  88. Comparison of IgA, IgG and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 vaccines.
    Tomabu Adjobimey, Julia Meyer, Leander Sollberg, Michael Bawolt, Christina Berens, Peđja Kovačević, Anika Trudić, Marijo Parčina, Achim M. Hoerauf · 2021 · Research Square
  89. M protein ectodomain-specific immunity restrains SARS-CoV-2 variants replication
    Yibo Tang, Kaiming Tang, Yunqi Hu, Zi‐Wei Ye, Wanyu Luo, Cuiting Luo, Hehe Cao, Ran Wang, Xinyu Yue, Dejian Liu et al. · 2024 · Frontiers in Immunology
  90. Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
    Weitong Yao, Yujun Li, Danting Ma, Xu-Dong Hou, Haimin Wang, Xiaojuan Tang, Dechun Cheng, He Zhang, Chengzhi Du, Hong Pan et al. · 2023 · Microbiology Spectrum
  91. Addressing Inequality in the COVID-19 Pandemic in Africa: A Snapshot from Clinical Symptoms to Vaccine Distribution
    Ana Catarina Pêgo, Illyane Sofia Lima, Raffaella Gozzelino · 2024 · COVID
  92. The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?
    Carlos Peña‐Bates, Ricardo Lascuraín, Vianney Francisco Ortiz-Navarrete, Leslie Chávez‐Galán · 2024 · Heliyon
  93. Respiratory mucosal vaccines: Applications, delivery strategies and design considerations
    Tingting Shi, Yuqing Ye, Ziyi Fan, Qingliang Yang, Ying Ma, Jesse Zhu · 2025 · Biomedicine & Pharmacotherapy
  94. Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines
    Jeswin Joseph, Kandan Sethumadhavan, Priyanca Ahlawat, Malavika Prakash, Gayatri Kandpal, Gowtham Raj, Harshal Srivastava, Packirisamy Charulekha, Aswin K Dev, Akshaya Radhakrishnan et al. · 2025 · ACS Nano
  95. Coronavirus (COVID-19) vaccines
    Mario Blekić, Blaženka Kljaić Bukvić · 2021 · Liječnički vjesnik
  96. A prospective multicenter study on cutaneous reactions reported after Sinopharm COVID ‐19 vaccination
    Ahmed M. Shawky, Emad Mahmoud El-Rewiny, Khaled Mohamed Gharib, Manar Sallam, Mofreh Mansour, Mahmoud A. Rageh · 2022 · International Journal of Dermatology
  97. Immunogenicity and protective efficacy of a DNA vaccine inducing optimal expression of the SARS-CoV-2 S gene in hACE2 mice
    Zhuo-xin Li, Sheng Feng, He Zhang et al. · 2022 · Archives of Virology
  98. A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults
    Deyan Luo, Hongxing Pan, Peng He, Xiaolan Yang, Tao Li, Nianzhi Ning, Xin De Fang, Wenjing Yu, Mingwei Wei, Hui Gao et al. · 2022 · Clinical and Translational Medicine
  99. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
  100. Herpetic endotheliitis and stromal keratitis following inactivated COVID ‐19 vaccination
    Mehrdad Mohammadpour, Hossein Farrokhpour, Reza Sadeghi · 2022 · Clinical Case Reports